|Systematic (IUPAC) name|
|Metabolism||Rapidly hydrolyzed to ampicillin|
|CAS Registry Number|
|Molecular mass||465.519 g/mol|
|(what is this?)|
Semi-synthetic antibiotic related to penicillin.
The relatively small chemical difference between ampicillin and benzylpenicillin not only allows for substantial oral activity but also results in a substantial broadening of antimicrobial spectrum so as to allow for use against many Gram-negative bacteria. Many devices have been employed in order to enhance still further the oral absorption of ampicillin. Bacampicillin is a prodrug of ampicillin designed for this purpose.
An azidopenicillin sodium salt (1) is reacted with mixed carbonate ester 2 (itself prepared from acetaldehyde and ethyl chloroformate) to give ester 3. Reduction of the azido linkage witrh hydrogen and a suitable catalyst produces bacampillin (4). Both enantiomers are active. The drug is rapidly absorbed from the gastrointestinal tract and is quickly cleaved by serum esterases to bioactive ampicillin, acetaldehyde, CO2 and ethanol.
- Bodin NO; Ekström B; Forsgren U et al. (November 1975). "Bacampicillin: a New Orally Well-Absorbed Derivative of Ampicillin". Antimicrob Agents Chemother 8 (5): 518–25. PMC 429411. PMID 1211909.
- B. A. Ekstrom, O. K. J. Kovacs, and B. O. H. Sjoberg, DE 2311328 (1973). Chem. Abstr., 80, 14921q(1974).
- B. A. Ekstrom, B. O. H. Sjoberg, DE 2144457 ; eidem, U.S. Patent 3,873,521 and U.S. Patent 3,939,270 (1972, 1975 and 1976 all to Astra).
|This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it.|